New England Research & Management’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,950
Closed -$227K 164
2023
Q2
$227K Sell
5,950
-100
-2% -$3.61K 0.13% 128
2023
Q1
$218K Buy
+6,050
New +$267K 0.13% 137
2022
Q4
Sell
-9,950
Closed -$458K 171
2022
Q3
$458K Buy
+9,950
New +$475K 0.29% 108

Other funds holding OVV

New England Research & Management's OVV Position: Q3 2023 in Review

New England Research & Management sold out of Ovintiv (OVV) in Q3 2023, closing a stake of 5,950 shares — an estimated $227K sold.

New England Research & Management first reported a position in OVV in Q3 2022 and held it in 3 quarters. The position peaked at $458K in Q3 2022. 448 funds tracked by Wall St. Rank hold OVV as of Q3 2023.

  • New England Research & Management reported no remaining Ovintiv position as of Q3 2023 after selling out during the quarter.
  • New England Research & Management sold 5,950 Ovintiv shares in Q3 2023, an estimated $227K.
  • New England Research & Management first reported a position in Ovintiv in Q3 2022 and held it in 3 quarters.
  • New England Research & Management's Ovintiv position peaked at $458K in Q3 2022.
  • 448 funds tracked by Wall St. Rank held Ovintiv as of Q3 2023.

Based on New England Research & Management's 13F filing for Q3 2023, filed 10 Oct 2023.